American Pharmaceutical posted Novartis Issues Recall of Promacta® 12.5 mg for Oral Suspension American Pharmaceutical Melrose Park, IL:

Novartis Issues Recall of Promacta® 12.5 mg for Oral Suspension

Novartis has announced a voluntary recall of three lots of Promacta (eltrombopag) 12.5 mg for oral suspension to the consumer level.

Novartis Issues Recall of Promacta® 12.5 mg for Oral Suspension
QR Code
Embed the QR code on your website:
Download
Copy